Literature DB >> 21778926

Incremental prognostic value of myocardial perfusion single photon emission computed tomography for patients with diabetes and chronic kidney disease.

Chio Okuyama1, Kenichi Nakajima, Tsuguru Hatta, Shigeyuki Nishimura, Hideo Kusuoka, Akira Yamashina, Tsunehiko Nishimura.   

Abstract

PURPOSE: This study estimates whether myocardial perfusion single photon emission computed tomography (SPECT) can predict the prognostic risk of cardiac events among patients with diabetes and relatively mild chronic kidney disease (CKD).
METHODS: Data from 2423 patients in the Japanese Assessment of Cardiac Events and Survival Study were examined. Patients were classified into group A (diabetes-, CKD-), B (diabetes-, CKD+), C (diabetes+, CKD-), and D (diabetes+, CKD+). After 3 years of follow-up, the incidence of cardiac events and the ability of myocardial perfusion SPECT to estimate prognosis were evaluated.
RESULTS: A total of 119 (4.9%) events (28 cardiac deaths, 25 myocardial infarctions, and 66 severe heart failures) occurred. Each type of event occurred more frequently in CKD compared with non-CKD groups with both diabetic and nondiabetic populations. Risk was higher in patients with high summed stress scores. Risk gradually increased in nondiabetic groups according to the decrease in the estimated glomerular filtration rate and roughly consisted of two diabetic groups with a cutoff of eGFR equal to 50 ml/min.
CONCLUSION: A high incidence of cardiac events is associated with CKD in both nondiabetic and diabetic patients. Summed stress scores obtained by myocardial perfusion SPECT have a highly incremental value for predicting the cardiac prognosis of patients with diabetes and CKD. These scores are useful for the risk stratification of asymptomatic patients with relatively mild renal dysfunction requiring neither dialysis nor renal transplantation.

Entities:  

Mesh:

Year:  2011        PMID: 21778926     DOI: 10.1097/MNM.0b013e3283495787

Source DB:  PubMed          Journal:  Nucl Med Commun        ISSN: 0143-3636            Impact factor:   1.690


  6 in total

Review 1.  Prognosis in the era of comparative effectiveness research: where is nuclear cardiology now and where should it be?

Authors:  Leslee J Shaw; Fadi G Hage; Daniel S Berman; Rory Hachamovitch; Ami Iskandrian
Journal:  J Nucl Cardiol       Date:  2012-10       Impact factor: 5.952

2.  Incremental prognostic value of SPECT-MPI in chronic kidney disease: A reclassification analysis.

Authors:  Amjad M Ahmed; Waqas T Qureshi; Wesley T O'Neal; Fatima Khalid; Mouaz H Al-Mallah
Journal:  J Nucl Cardiol       Date:  2017-01-03       Impact factor: 5.952

3.  Prognostic value of left ventricular dyssynchrony evaluated by gated myocardial perfusion imaging in patients with chronic kidney disease and normal perfusion defect scores.

Authors:  Hiroaki Mori; Satoshi Isobe; Susumu Suzuki; Kazumasa Unno; Ryota Morimoto; Naoaki Kano; Takahiro Okumura; Yoshinari Yasuda; Katsuhiko Kato; Toyoaki Murohara
Journal:  J Nucl Cardiol       Date:  2017-04-21       Impact factor: 5.952

4.  Prognostic value of myocardial perfusion single photon emission computed tomography for major adverse cardiac cerebrovascular and renal events in patients with chronic kidney disease: results from first year of follow-up of the Gunma-CKD SPECT multicenter study.

Authors:  Shu Kasama; Takuji Toyama; Makito Sato; Hirokazu Sano; Tetsuya Ueda; Toyoshi Sasaki; Takehiro Nakahara; Tetsuya Higuchi; Yoshito Tsushima; Masahiko Kurabayashi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-09-25       Impact factor: 9.236

5.  Negative predictive value of SPECT for the occurrence of MACE in a medium-sized clinic in the Netherlands.

Authors:  M J Bom; J M B Manders; R Uijlings; E A Badings; F M A C Martens
Journal:  Neth Heart J       Date:  2014-04       Impact factor: 2.380

Review 6.  Myocardial Ischemia Assessment in Chronic Kidney Disease: Challenges and Pitfalls.

Authors:  Susie F C Parnham; Jonathan M Gleadle; Carmine G De Pasquale; Joseph B Selvanayagam
Journal:  Front Cardiovasc Med       Date:  2014-12-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.